Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Athersys Inc (ATHX)

Athersys Inc (ATHX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Athersys to Host Third Quarter Financial Results Call

Athersys, Inc. (Nasdaq: ATHX) will release its third quarter 2019 financial results at approximately 4:00 PM Eastern Time on Wednesday, November 6, 2019, and will host a conference call shortly thereafter...

ATHX : 1.36 (+1.49%)
Athersys to Present at 2019 Cell & Gene Meeting on the Mesa

Athersys, Inc. (NASDAQ: ATHX) announced today that Dr. Gil Van Bokkelen, Chairman and CEO, will present at the annual Cell & Gene Meeting on the Mesa to be held October 2 -4 in Carlsbad, California.

ATHX : 1.36 (+1.49%)
Athersys Reports Second Quarter 2019 Results

Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended June 30, 2019.

ATHX : 1.36 (+1.49%)
Athersys to Host Second Quarter Financial Results Call

Athersys, Inc. (Nasdaq: ATHX) will release its second quarter 2019 financial results at approximately 4:00 PM Eastern Time on Wednesday, August 7, 2019, and will host a conference call shortly thereafter...

ATHX : 1.36 (+1.49%)
Global Translational Regenerative Medicines Market Outlook (2017-2026)

According to Stratistics MRC, the Global Translational Regenerative Medicines Market is growing at a CAGR of 13.9% from 2017 to 2026. Factors such as the increasing prevalence of degenerative diseases,...

ANIK : 57.40 (+0.77%)
ATHX : 1.36 (+1.49%)
BCLI : 3.95 (+1.02%)
CELGZ : 0.45 (+2.30%)
NVS : 86.70 (+0.90%)
Athersys to Present at Jefferies 2019 Healthcare Conference

Athersys, Inc. (NASDAQ: ATHX) announced today that Dr. Gil Van Bokkelen, Chairman and CEO, will present at the Jefferies 2019 Healthcare Conference taking place June 4-7, 2019 in New York City. Dr. Van...

ATHX : 1.36 (+1.49%)
Athersys to Participate in four Events at the International Society of Cell and Gene Therapy Conference

Athersys, Inc. (NASDAQ: ATHX) announced today its participation in several sessions at this year's International Society for Cell and Gene Therapy (ISCT) conference taking place May 29 - June 2, 2019 in...

ATHX : 1.36 (+1.49%)
Athersys Presents Data From Its Acute Respiratory Distress Syndrome Clinical Trial at American Thoracic Society International Conference

Athersys, Inc. (Nasdaq: ATHX) announced additional favorable data from its exploratory Phase 1/2 acute respiratory distress syndrome (ARDS) clinical trial. Dr. Geoff Bellingan, Medical Director at University...

ATHX : 1.36 (+1.49%)
Athersys Announces Fast Track Designation From FDA for MultiStem(R) Program for Acute Respiratory Distress Syndrome

Athersys, Inc. (Nasdaq: ATHX) announced today that its clinical program evaluating MultiStem(R) cell therapy for the treatment of Acute Respiratory Distress Syndrome ("ARDS") has received Fast Track designation...

ATHX : 1.36 (+1.49%)
Athersys Reports First Quarter 2019 Results

Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended March 31, 2019.

ATHX : 1.36 (+1.49%)
Athersys, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 8, 2019 / Athersys, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 8, 2019 at 4:30 PM Eastern Time.

ATHX : 1.36 (+1.49%)
Detailed Research: Economic Perspectives on Athersys, Crescent Point Energy, Snap-On, and Dover -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Athersys, Inc. (NASDAQ:ATHX), Crescent...

ATHX : 1.36 (+1.49%)
CPG : 3.88 (+2.37%)
SNA : 158.30 (+0.22%)
DOV : 95.98 (+0.07%)
Athersys (ATHX) Upgraded to Strong Buy: Here's What You Should Know

Athersys (ATHX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ATHX : 1.36 (+1.49%)
Athersys to Host Investor Day in New York City

Athersys, Inc. (Nasdaq: ATHX) announced today that the company will host an investor day on Tuesday, May 14, 2019. The event will focus on the Company's mission, core capabilities and technologies, as...

ATHX : 1.36 (+1.49%)
Athersys to Host First Quarter Financial Results Call

Athersys, Inc. (Nasdaq: ATHX) will release its first quarter 2019 financial results at approximately 4:00 PM Eastern Time on Wednesday, May 8, 2019, and will host a conference call shortly thereafter at...

ATHX : 1.36 (+1.49%)
Athersys to Participate in Two Upcoming Healthcare Conferences

Athersys, Inc. (NASDAQ: ATHX) announced today the Company's participation in two upcoming biotechnology and healthcare conferences. On April 4, Athersys will be part of the William Blair 3 Annual Late-Stage...

ATHX : 1.36 (+1.49%)
What Makes Athersys (ATHX) a New Buy Stock

Athersys (ATHX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ATHX : 1.36 (+1.49%)
Athersys Announces Financial Results for Fourth Quarter and Full Year 2018

Substantial progress over the year, advancing programs and

ATHX : 1.36 (+1.49%)
Athersys, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 14, 2019 / Athersys, Inc. (NASDAQ: ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 14, 2019, 2018 at 4:30 PM Eastern...

ATHX : 1.36 (+1.49%)
Athersys (ATHX) Q4 Earnings: What's in Store for the Stock?

During Athersys' (ATHX) Q4 conference call, investor focus will be on the company's progress with its investigational MultiStem cell therapy to treat various indications.

ATHX : 1.36 (+1.49%)
CATB : 4.80 (-2.04%)
CARA : 19.38 (+2.76%)
TLRY : 22.12 (+7.07%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI -1.48 , AIZ -0.25 , SBAC -1.85 , SO -0.22 , WELL -0.40
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar